[DPHARMA] YoY Annualized Quarter Result on 30-Jun-2018 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- -2.68%
YoY- 9.21%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 643,786 604,088 591,704 514,500 480,710 317,210 203,814 21.10%
PBT 86,746 74,236 74,204 52,340 49,528 35,328 41,210 13.19%
Tax -20,738 -17,656 -17,442 -10,368 -11,118 -11,790 -11,576 10.19%
NP 66,008 56,580 56,762 41,972 38,410 23,538 29,634 14.26%
-
NP to SH 66,008 56,580 56,762 41,972 38,434 24,692 29,634 14.26%
-
Tax Rate 23.91% 23.78% 23.51% 19.81% 22.45% 33.37% 28.09% -
Total Cost 577,778 547,508 534,942 472,528 442,300 293,672 174,180 22.09%
-
Net Worth 614,350 581,725 503,029 209,983 463,071 446,334 190,284 21.55%
Dividend
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Div 7,061 6,843 13,237 8,399 13,947 13,947 11,193 -7.38%
Div Payout % 10.70% 12.10% 23.32% 20.01% 36.29% 56.49% 37.77% -
Equity
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Net Worth 614,350 581,725 503,029 209,983 463,071 446,334 190,284 21.55%
NOSH 706,330 684,383 661,881 650,902 278,959 278,959 139,915 30.94%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 10.25% 9.37% 9.59% 8.16% 7.99% 7.42% 14.54% -
ROE 10.74% 9.73% 11.28% 19.99% 8.30% 5.53% 15.57% -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 91.17 88.27 89.40 183.76 172.32 113.71 145.67 -7.50%
EPS 9.34 8.26 8.52 6.44 13.76 8.44 21.18 -12.74%
DPS 1.00 1.00 2.00 3.00 5.00 5.00 8.00 -29.26%
NAPS 0.87 0.85 0.76 0.75 1.66 1.60 1.36 -7.16%
Adjusted Per Share Value based on latest NOSH - 650,902
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 66.93 62.80 61.51 53.49 49.97 32.98 21.19 21.10%
EPS 6.86 5.88 5.90 4.36 4.00 2.57 3.08 14.26%
DPS 0.73 0.71 1.38 0.87 1.45 1.45 1.16 -7.42%
NAPS 0.6387 0.6047 0.5229 0.2183 0.4814 0.464 0.1978 21.55%
Price Multiplier on Financial Quarter End Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 -
Price 3.03 1.62 1.37 1.30 2.25 2.04 2.65 -
P/RPS 3.32 1.84 1.53 0.71 1.31 1.79 1.82 10.52%
P/EPS 32.41 19.60 15.98 8.67 16.33 23.05 12.51 17.17%
EY 3.09 5.10 6.26 11.53 6.12 4.34 7.99 -14.63%
DY 0.33 0.62 1.46 2.31 2.22 2.45 3.02 -30.83%
P/NAPS 3.48 1.91 1.80 1.73 1.36 1.28 1.95 10.12%
Price Multiplier on Announcement Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 22/08/16 25/08/15 -
Price 2.49 3.15 1.41 1.08 2.03 2.14 2.40 -
P/RPS 2.73 3.57 1.58 0.59 1.18 1.88 1.65 8.74%
P/EPS 26.64 38.10 16.44 7.20 14.73 24.18 11.33 15.29%
EY 3.75 2.62 6.08 13.88 6.79 4.14 8.83 -13.29%
DY 0.40 0.32 1.42 2.78 2.46 2.34 3.33 -29.73%
P/NAPS 2.86 3.71 1.86 1.44 1.22 1.34 1.76 8.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment